Taking diabetes medication helps lower medical costs, slightly

Mar 18, 2011 By David Pittman

A new study in the journal Health Services Research shows that diabetes patients who do a better job of taking their medication have slightly lower health care costs.

However, “it’s not a huge effect,” said lead investigator Bruce Stuart, a professor at the University of Maryland School of Pharmacy in Baltimore.

Researchers found that patients who take statin drugs to control cholesterol levels for their could realize $832 in savings over three years if they increased their by 10 percent. The same increase in medication adherence from patients taking ACE-inhibitors, a class of antihypertensive drug, was associated with $285 lower Medicare costs over a three-year period. A 10 percentage-point increase is equal to taking three more pills a month if a patient were prescribed one a day for a 30-day month.

“This is a commonsensical notion that better adherence to drugs that are recommended should have impacts that could plausibly save money,” Stuart said. “Our conclusion is, yeah, it’s there, but it's a pretty modest saving.”

Stuart and colleagues followed about 4,000 Medicare patients who had diabetes diagnoses. Researchers asked the patients to track their pill counts and derived estimated spending costs from Medicare data. Their findings conflict with some published data on the correlation between medication adherence and savings.

“There is literature out there that suggests that you could cut the total health spending by a third or more if you just made people more adherent with the drugs that they should be taking,” Stuart said.

Studies have a difficult time linking medication adherence with cost savings. “It may be the people who take their pills regularly also regularly exercise and watch their diet and conform to all the requirements, so it’s hard to separate them,” said Robert Henry, president of medicine and science for the American Diabetes Association.

Because factors other than medication adherence influence a patient’s health, other outcomes such as overall quality of life are also tough to measure. “I think a general statement can be made that the more compliant one is, the better their quality of life, the lower their complication rate and probably a greater longevity,” Henry said.

Explore further: New rice contamination reported in China

More information: Stuart B, et al. Does medication adherence lower Medicare spending among beneficiaries with diabetes? Health Services Research online 2011.

Related Stories

Broken bones and medication

Oct 05, 2010

Although one in four women over 50 develops osteoporosis, most are unaware they have the disease — something Professor Suzanne Cadarette would like to change.

Recommended for you

Americans still making unhealthy choices, CDC reports

6 hours ago

(HealthDay)—The overall health of Americans isn't improving much, with about six in 10 people either overweight or obese and large numbers engaging in unhealthy behaviors like smoking, heavy drinking or ...

User comments : 0

More news stories

If you can remember it, you can remember it wrong

(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...

B vitamins could delay dementia

(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...

Reducing caloric intake delays nerve cell loss

Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...

New sleeping pill poised to hit US markets

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Changing cancer's environment to halt its spread

By studying the roles two proteins, thrombospondin-1 and prosaposin, play in discouraging cancer metastasis, a trans-Atlantic research team has identified a five-amino acid fragment of prosaposin that significantly reduces ...

New method for producing clean hydrogen

Duke University engineers have developed a novel method for producing clean hydrogen, which could prove essential to weaning society off of fossil fuels and their environmental implications.